| abstract |
A combination of: (i) 5-aminosalicylic acid, or a pharmacologically acceptable salt thereof, or a derivative thereof selected from the group consisting of: sulfasalazine, olsalazine, and balsalazide, and (ii) a vitamin from group D, and ( iii) at least one physiologically acceptable excipient or a pharmaceutical composition comprising said combination for use in the prevention and / or treatment of colorectal cancer in a subject. |